HomeArticlesToday's HighlightsAgenus fincances through Tokenization. Amgen's critics hit hard. Why BioTime could thrive on OncoCyte news
Today's Highlights
Premium

Agenus fincances through Tokenization. Amgen's critics hit hard. Why BioTime could thrive on OncoCyte news

AGENUS Agenus (AGEN)  announced the upcoming launch of its Biotech Electronic Security Token (BEST);  the first digital security offering in healthcare. Tokenization enables qualified investors to dir...
P

Prohost Biotech

1 min read
3
0

Unlock Premium Content

This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.

Unlimited articles
Expert analysis
Research reports

Comments (0)

Please sign in to join the discussion